Binder Information
| Binder General Information | Top | |||
|---|---|---|---|---|
| Binder ID |
BQ9RI5
|
|||
| Binder Name |
Glycylglycylglycine
|
|||
| Synonyms |
Triglycine; Glycyl-glycyl-glycine; H-Gly-Gly-Gly-OH; Gly-Gly-Gly; Diglycylglycine; N-(N-Glycylglycyl)glycine; Glycine, glycylglycyl-; 2-(2-(2-Aminoacetamido)acetamido)acetic acid; GlyGlyGly; UNII-CVK73ZDQ8B; 2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetic acid; MFCD00036223; Gly-Gly-Gly-OH; CVK73ZDQ8B; CHEMBL54278; Glycine, N-(N-glycylglycyl)-; Glycine, N-(N-glycylglycyl)- (8CI)(9CI); [2-(2-Amino-acetylamino)-acetylamino]-acetic acid; Glycylpeptide; Triglycine (van); NSC46707; EINECS 209-122-0; NSC 46707; Maybridge1_006812; (Gly)3; ACMC-209lo4; Glycylglycylglycine, 98+%; SCHEMBL98565; N-(N-GLYCYLGLYCYL)-Glycine; CTK1H1133; HMS560N14; DTXSID80204140; ZINC1678871; ANW-32354; BDBM50188484; NSC-46707; SBB071512; AKOS005207234; DS-7430; MCULE-8930278374; AK161962; SC-15976; SY025319; FT-0690006; G0126; Gly-Gly-Gly, BioUltra, >=99.0% (NT); (([(Aminoacetyl)amino]acetyl)amino)acetic acid; K-9925; (([(Aminoacetyl)amino]acetyl)amino)acetic acid #; 2-[2-(2-aminoacetylamino)acetylamino]acetic acid; 556G332; Q27132936; Triglycine, United States Pharmacopeia (USP) Reference Standard; 2-[[2-[(2-Aminoacetyl)amino]acetyl]amino]acetic Acid (Triglycine)
Click to Show/Hide
|
|||
| Binder Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C6H11N3O4
|
|||
| Canonical SMILES |
C(C(=O)NCC(=O)NCC(=O)O)N
|
|||
| InChI |
1S/C6H11N3O4/c7-1-4(10)8-2-5(11)9-3-6(12)13/h1-3,7H2,(H,8,10)(H,9,11)(H,12,13)
|
|||
| InChIKey |
XKUKSGPZAADMRA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:63961
|
|||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.